Immuneering Corporation (IMRX) Tops Q1 EPS by 5c

Immuneering Corporation (NASDAQ: IMRX) reported Q1 EPS of ($0.44), $0.05 better than the analyst estimate of ($0.49).

For earnings history and earnings-related data on Immuneering Corporation (IMRX) click here.

You May Also Be Interested In

• Calumet Specialty Products Partners (CLMT) PT Raised to $47 at UBS
• UBS Reiterates Buy Rating on Abercrombie & Fitch (ANF) as Q2 Beat Expected
• Hennessy VII shareholders approve merger with ONE Nuclear